KCL003-CF1

KCL003/CF-1

Cell Line Name KCL003/CF-1
Cell Line Status Currently available
Cell Type Human Embryonic
Grade Research
Source Human embryo / blastocyst
Source type Cryopreserved
Consent Status Donor consent was reviewed by the UK Steering Committee and was found to be consistent with the Steering Committee Code of Practice for the Use of Human Stem Cell Lines.  
Date cell line derived 01 May 2003  
Ethical Statement In the opinion of the Steering Committee for the UK Stem Cell Bank and the use of Human Stem Cell Lines, the derivation of the stem cell line is consistent with UK ethical guidelines
Depositor Kings College London  
Depositing Centre Kings College, London
Country of Origin United Kingdom
Depositor Contact Details cecilia.soh@kcl.ac.uk  
Journal Reference Stem cell line encoding the cystic fibrosis mutation - SJ Pickering et al. Vol 10. No 3. 2005 390-397 Reproductive BioMedicine  
SCSC No. SCSC-06-28(2)  
UKSCB Accession No. R-08-030  
Distribution Bank No. d01  
Passage No. p19  
Feeder Cell Type Mouse embryo fibroblast
Basel Medium DMEM  
Protein Source FBS
Growth Factors bFGF and LIF
Incubation Conditions 37°C, 5% CO2, >95% RH, Subculture: manual cutting  
Culture Morphology Embryonic stem cell colonial morphology
Preservation Method Vitrified  
Viability >80%
DNA Profile Human
Karyotype 46,XY CF deltaF508 mutation  
Characterisation Panel Awaiting Confirmation of Characterisation Panel Tests
Sterility Test No contamination detected by EU Pharmocopeal Sterility Test
Mycoplasm Screen Mycoplasma not detected by Mycoplasma PCR or Culture
Viral Screen Human Virus Panel (HIV, HTLV, HBV, HCV, EBV, CMV) not detected by PCR

Assuring the quality of stem cells for the scientific and clinical community

NIBSC MRC bbsrc toxbank screeTox screeTox